DIABETES RESEARCH AND CLINICAL PRACTICE

Scope & Guideline

Exploring breakthroughs in endocrinology and diabetes care.

Introduction

Welcome to the DIABETES RESEARCH AND CLINICAL PRACTICE information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of DIABETES RESEARCH AND CLINICAL PRACTICE, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0168-8227
PublisherELSEVIER IRELAND LTD
Support Open AccessNo
CountryIreland
TypeJournal
Convergefrom 1985 to 2024
AbbreviationDIABETES RES CLIN PR / Diabetes Res. Clin. Pract.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE 00000, IRELAND

Aims and Scopes

The journal 'Diabetes Research and Clinical Practice' primarily focuses on advancing the understanding, prevention, and management of diabetes through innovative research and clinical practices. It aims to disseminate high-quality studies that enhance clinical outcomes for patients with diabetes and related metabolic disorders.
  1. Clinical and Epidemiological Research:
    The journal publishes studies that explore the clinical aspects of diabetes, including epidemiological trends, risk factors, and the impact of diabetes on overall health outcomes.
  2. Innovative Treatment Approaches:
    Research on novel therapeutic strategies, including pharmacological treatments, dietary interventions, and lifestyle modifications aimed at improving glycemic control and patient quality of life.
  3. Diabetes Complications and Comorbidities:
    Articles focusing on the prevention, diagnosis, and management of diabetes-related complications such as cardiovascular disease, kidney disease, and neuropathy.
  4. Patient-Centered Care:
    Studies emphasizing the importance of patient engagement, education, and self-management strategies in diabetes care.
  5. Health Policy and Economic Evaluations:
    Research assessing the implications of health policies on diabetes management, including cost-effectiveness analyses of treatments and interventions.
  6. Technological Advancements in Diabetes Management:
    Exploration of digital health tools, continuous glucose monitoring systems, and telemedicine in managing diabetes effectively.
Recent publications in 'Diabetes Research and Clinical Practice' indicate a shift towards several emerging themes that are gaining traction in diabetes research. These trends reflect the evolving landscape of diabetes care and the need for more comprehensive approaches to management.
  1. Digital Health Technologies:
    There is an increasing focus on the integration of digital tools, such as mobile health applications and telemedicine, in diabetes management, reflecting the need for accessible and patient-centered care.
  2. Personalized Medicine Approaches:
    Emerging research is emphasizing personalized treatment plans based on individual patient profiles, including genetic, metabolic, and lifestyle factors, to optimize diabetes management.
  3. Mental Health and Diabetes:
    The intersection of mental health, diabetes distress, and patient outcomes is gaining attention, highlighting the importance of psychological well-being in managing diabetes.
  4. Diabetes and Cardiovascular Risk Management:
    A growing body of research is examining the link between diabetes and cardiovascular disease, with studies focusing on prevention and management strategies for at-risk populations.
  5. Longitudinal Studies on Diabetes Progression:
    Emerging interest in long-term studies that track the progression of diabetes and its complications over time, providing insights into effective management strategies.

Declining or Waning

Over recent years, certain themes in diabetes research appear to be losing prominence or frequency in publications. This may reflect shifts in research priorities, funding, or emerging areas of interest that overshadow previously popular topics.
  1. Traditional Dietary Interventions:
    There seems to be a decline in studies focusing solely on traditional dietary approaches to diabetes management, as more attention shifts towards integrative and personalized nutrition strategies.
  2. Single-Drug Efficacy Studies:
    Research concentrating on the efficacy of single-drug treatments is waning, likely due to a growing focus on combination therapies and multi-faceted treatment approaches.
  3. Basic Science Research in Diabetes:
    While foundational research remains important, there is a noticeable shift towards clinical and translational studies that directly impact patient care and outcomes.
  4. General Public Awareness Campaigns:
    The emphasis on broad public awareness campaigns about diabetes is decreasing, possibly due to a pivot towards targeted interventions that address specific populations or high-risk groups.

Similar Journals

Journal of Diabetes and Metabolic Disorders

Leading the Charge in Metabolic Disorder Research
Publisher: SPRINGER INT PUBL AGISSN: Frequency:

The Journal of Diabetes and Metabolic Disorders, published by SPRINGER INT PUBL AG, is a premier academic journal dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. With an E-ISSN of 2251-6581, this journal plays a crucial role in disseminating high-quality research findings from 2012 to 2024, serving as a valuable resource for researchers, practitioners, and students alike. Notably, it has achieved impressive rankings, being placed in the Q2 quartile for Internal Medicine and Q3 for Endocrinology, Diabetes, and Metabolism in 2023, reflecting its influence within the scientific community. The Journal’s commitment to open access ensures that its comprehensive articles, encompassing topics from metabolic disorders to novel therapeutic approaches, are readily available to a global audience. Position yourself at the forefront of medical advancements—contribute to and benefit from the pivotal research presented in this journal.

DIABETES OBESITY & METABOLISM

Connecting researchers to enhance patient care in endocrinology.
Publisher: WILEYISSN: 1462-8902Frequency: 12 issues/year

DIABETES OBESITY & METABOLISM, published by Wiley, is a premier international journal dedicated to the fields of endocrinology, diabetes, and metabolic disorders. With an impressive impact factor and its status as a Q1 journal in multiple categories—including Endocrinology and Internal Medicine—this publication is highly regarded in the academic community. Since its inception in 1999, the journal has served as a crucial platform for the dissemination of cutting-edge research, reviews, and clinical studies, driving advancements in understanding and treatment of diabetes and obesity. Researchers and professionals alike benefit from its rigorous peer-review process and extensive reach, as it aims to bridge the gap between laboratory findings and clinical applications. Although not an Open Access journal, articles are accessible through institutional subscriptions, ensuring that vital knowledge reaches those committed to enhancing patient care and expanding the scientific body of work in these pivotal areas.

Cardiovascular Journal of Africa

Elevating the standard of cardiovascular practice in Africa.
Publisher: CLINICS CARDIVE PUBL PTY LTDISSN: 1995-1892Frequency: 6 issues/year

Welcome to the Cardiovascular Journal of Africa, an esteemed publication dedicated to advancing the fields of Cardiology and Cardiovascular Medicine. Established in 1994 and published by CLINICS CARDIVE PUBL PTY LTD, this journal serves as a vital platform for researchers, practitioners, and students interested in innovative cardiovascular research and clinical practice within the African context and beyond. With a Q3 ranking in both relevant categories as of 2023, this journal contributes significantly to the growing corpus of medical literature. Although access is non-open, the journal features a diverse array of peer-reviewed articles that explore groundbreaking findings and practical applications in cardiovascular health, fostering knowledge exchange among professionals. Situated in South Africa, the Cardiovascular Journal of Africa is not just a repository of academic research; it is a cornerstone in the fight against cardiovascular diseases, addressing the unique challenges faced by populations across the continent.

Journal of Diabetes

Elevating the conversation in endocrinology and diabetes.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

DIABETES-METABOLISM RESEARCH AND REVIEWS

Pioneering Research for a Healthier Tomorrow
Publisher: WILEYISSN: 1520-7552Frequency: 8 issues/year

DIABETES-METABOLISM RESEARCH AND REVIEWS, published by WILEY, is an esteemed academic journal focusing on the forefront of research in the fields of endocrinology, diabetes, and metabolism. Since its inception in 1999, this journal has become a crucial resource for researchers, professionals, and students, boasting an impressive impact factor that reflects its high citation rates and contribution to the field. With a 2023 classification of Q1 in several categories including Endocrinology and Internal Medicine, it ranks among the top journals globally, demonstrating its significant influence and authority. The journal serves as a platform for the dissemination of innovative research, reviews, and methodologies that advance understanding and treatment of metabolic disorders. By offering valuable insights and fostering collaboration within the scientific community, DIABETES-METABOLISM RESEARCH AND REVIEWS is essential reading for anyone involved in diabetes research and clinical practice.

DIABETES & METABOLISM

Leading the Way in Diabetes and Metabolic Studies
Publisher: MASSON EDITEURISSN: 1262-3636Frequency: 6 issues/year

DIABETES & METABOLISM, published by MASSON EDITEUR in France, is a leading academic journal dedicated to the fields of endocrinology, diabetes, and metabolism. With an impressive Impact Factor reflecting its esteemed reputation, the journal has been ranked in the Q1 category across multiple disciplines including Endocrinology, Internal Medicine, and more, showcasing its significance and influence in the scientific community. Since its inception in 1996 and continuing its contributions through 2024, DIABETES & METABOLISM systematically disseminates high-quality research findings, reviews, and clinical studies aimed at furthering knowledge and encouraging innovation in metabolic diseases. Although not an open-access journal, it ensures that valuable research is accessible to a broad audience through institutional subscriptions and affiliations. As a key resource for researchers, clinicians, and students alike, this journal stands at the forefront of advancing understanding and treatment options in diabetes and related metabolic disorders, making it an essential addition to any academic library.

Journal of Clinical and Translational Endocrinology

Bridging Lab Discoveries with Patient Care.
Publisher: ELSEVIERISSN: 2214-6237Frequency: 4 issues/year

Journal of Clinical and Translational Endocrinology is a peer-reviewed open access journal published by Elsevier that has been serving the endocrinology community since its inception in 2014. With an ISSN of 2214-6237, this journal focuses on the critical intersection of clinical and translational research in endocrinology, diabetes, and metabolism, offering insights that bridge laboratory discoveries with patient care. It holds a commendable position in the field, ranking Q3 for Endocrinology and Q2 for Endocrinology, Diabetes, and Metabolism, reflecting its rigorous standards and relevance to contemporary research. Situated in the Netherlands, the journal’s aim is to foster knowledge dissemination and collaboration among professionals, researchers, and students alike, ensuring high visibility in a rapidly evolving field. The journal is committed to open access, allowing immediate access to research findings, thus maximizing their impact and facilitating advancements in clinical practice and research. With an H index that showcases its contribution to the field, Journal of Clinical and Translational Endocrinology is an essential resource for anyone invested in advancing endocrinological science.

Diabetes & Metabolic Syndrome-Clinical Research & Reviews

Shaping the Future of Metabolic Disorders
Publisher: ELSEVIER SCI LTDISSN: 1871-4021Frequency: 6 issues/year

Diabetes & Metabolic Syndrome-Clinical Research & Reviews is a leading peer-reviewed journal published by ELSEVIER SCI LTD in the field of endocrinology, diabetes, and internal medicine. With an impressive impact factor evidenced by its high rankings, this journal is positioned in the top quartile (Q1) across multiple categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine. Spanning from 2007 to 2024, it serves as a vital resource for researchers, healthcare professionals, and students alike, offering comprehensive reviews and innovative clinical research related to metabolic disorders. Located in the Netherlands, the journal emphasizes an open-access approach, ensuring valuable insights are available to a global audience. By publishing high-quality and impactful articles, Diabetes & Metabolic Syndrome not only contributes to the advancement of scientific knowledge but also plays a crucial role in shaping clinical practices and enhancing patient care in the realm of diabetes and metabolic syndrome.

Practical Diabetes

Exploring innovative strategies in diabetes management.
Publisher: JOHN WILEY & SONS LTDISSN: 2047-2897Frequency: 9 issues/year

Practical Diabetes is an esteemed journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Published by John Wiley & Sons Ltd, this journal serves as a vital resource for healthcare professionals, researchers, and students seeking to explore the latest findings and practical applications in the field of endocrinology. With an ISSN of 2047-2897, it has established itself as a respected outlet for impactful research since its inception in 2011, with a convergence period extending until 2024. Although currently listed in Q4 for Endocrinology, Diabetes, and Metabolism and Q3 for Internal Medicine, the journal is committed to improving its rank and increasing its relevance in a competitive academic landscape. While not an open-access publication, Practical Diabetes provides valuable insights and evidence-based practices that are crucial for improving patient outcomes. Researchers and practitioners alike will find a wealth of knowledge to inform their work and enhance their understanding of diabetes management, making this journal an essential addition to any academic library collection.

JOURNAL OF DIABETES AND ITS COMPLICATIONS

Exploring the complexities of diabetes and its impact.
Publisher: ELSEVIER SCIENCE INCISSN: 1056-8727Frequency: 6 issues/year

JOURNAL OF DIABETES AND ITS COMPLICATIONS is a distinguished peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the knowledge and management of diabetes and its multifaceted complications. With an ISSN of 1056-8727 and E-ISSN 1873-460X, this journal has established its significance in the fields of Endocrinology, Diabetes and Metabolism, and Internal Medicine, as reflected in its Q2 and Q1 quartile rankings for 2023, and its commendable Scopus rankings. The journal, which has been converging knowledge since 1992 and continues to publish vital research until 2024, serves as a platform for researchers, professionals, and students aiming to delve deeper into the mechanisms, treatment, and implications of diabetes and its related disorders. While access is not open, the journal remains a critical resource for those invested in understanding and combating the challenges posed by diabetes, ultimately contributing to better health outcomes.